Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts.

Fibroblast proliferation and extracellular matrix accumulation are two major events occurring in fibrosis. Hepatic stellate cells are the major collagen-producing cells of the liver and are transformed into proliferative myofibroblasts following activation. Whether proliferation and extracellular matrix production are regulated by the same cytokines is not known. Monocyte-conditioned medium obtained from pigs with yellow phosphorus-induced hepatic fibrosis increased the collagen production by cultured procine myofibroblasts. Liver biopsies from these same fibrotic animals had increased levels of collagen alpha 1(I) and alpha 1(III) mRNA compared to control animals. Preincubation with platelet-derived growth factor (PDGF) B/B antibody significantly reduced the collagen-stimulating ability of the monocyte-conditioned medium. Recombinant PDGF stimulated proliferation in nonconfluent myofibroblasts and stimulated collagen production in confluent cultures of myofibroblasts without increasing cell number, suggesting that these events can occur independent of each other. Pentoxifylline and one of its active metabolites (metabolite-1) inhibited PDGF-stimulated collagen production in cultured porcine myofibroblasts. These results demonstrate the importance of PDGF in the pathogenesis of liver fibrosis and provide evidence that pentoxifylline interferes with PDGF-mediated events during experimental liver fibrosis.

[1]  T. C. Peterson,et al.  Drug-metabolizing enzymes in rat liver myofibroblasts. , 1998, Biochemical pharmacology.

[2]  A. Mallat,et al.  Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast‐like cells , 1997, Hepatology.

[3]  B. Askari,et al.  LYMPHOTOXIN-β AND TNF REGULATION IN T CELL SUBSETS: DIFFERENTIAL EFFECTS OF PGE2 , 1997 .

[4]  A. Gentilini,et al.  Inhibition by pentoxifylline of extracellular signal‐regulated kinase activation by platelet‐derived growth factor in hepatic stellate cells , 1996, British journal of pharmacology.

[5]  T. C. Peterson.  Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors. , 1996, Biochemical pharmacology.

[6]  A. Gressner,et al.  Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts. , 1996, Biochemical pharmacology.

[7]  T. C. Peterson,et al.  Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. , 1996, Immunopharmacology.

[8]  J. Fox,et al.  Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts. , 1995, Biochemical Journal.

[9]  J. Peltonen,et al.  Platelet-derived growth factor isoforms PDGF-AA, -AB and -BB exert specific effects on collagen gene expression and mitotic activity of cultured human wound fibroblasts. , 1995, Biochemical and biophysical research communications.

[10]  J. Seyer,et al.  Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. , 1994, The Biochemical journal.

[11]  R. Allman,et al.  Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. , 1994, The American journal of pathology.

[12]  R. Isbrucker,et al.  In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. , 1994, Immunopharmacology.

[13]  G. Sobue,et al.  cAMP-dependent differential regulation of extracellular matrix (ECM) gene expression in cultured rat Schwann cells , 1994, Brain Research.

[14]  M. Lagarde,et al.  Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. , 1994, Biochemical pharmacology.

[15]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[16]  T. C. Peterson.  Pentoxifylline prevents fibrosis in an animal model and inhibits platelet‐derived growth factor–driven proliferation of fibroblasts , 1993, Hepatology.

[17]  R. Isbrucker,et al.  Fibroproliferation in liver disease: Role of monocyte factors , 1992, Hepatology.

[18]  D. Malatjalian,et al.  Monocyte aryl hydrocarbon hydroxylase (AHH) activity mimics Kupffer cell and hepatocyte AHH activity in an animal model of liver disease. , 1991, Canadian journal of physiology and pharmacology.

[19]  R. Diegelmann,et al.  A microassay to quantitate collagen synthesis by cells in culture. , 1990, Analytical biochemistry.

[20]  C. Hart,et al.  Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. , 1989, The Journal of biological chemistry.

[21]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[22]  C. Williams,et al.  Depression of peripheral blood monocyte aryl hydrocarbon hydroxylase activity in patients with liver disease: Possible involvement of macrophage factors , 1987, Hepatology.

[23]  H. Bessler,et al.  Effect of Pentoxitylline on the Phagocytic Activity, cAMP Levels, and Superoxide Anion Production by Monocytes and Polymorphonuclear Cells , 2005 .

[24]  K. Renton,et al.  Kupffer cell factor mediated depression of hepatic parenchymal cell cytochrome P-450. , 1986, Biochemical pharmacology.

[25]  M. Pinzani.  Novel insights into the biology and physiology of the Ito cell. , 1995, Pharmacology & therapeutics.

[26]  A. Gressner,et al.  Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm. , 1994, Annales de biologie clinique.